# An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

> **NCT06671405** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 59 (actual)

## Conditions studied

- Dyslipidaemia

## Interventions

- **DRUG:** AZD0780
- **DRUG:** Itraconazole
- **DRUG:** Carbamazepine
- **DRUG:** Midazolam
- **DRUG:** Ethinyl estradiol/levonorgestrel

## Key facts

- **NCT ID:** NCT06671405
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-25
- **Primary completion:** 2025-02-17
- **Final completion:** 2025-02-17
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671405, "An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06671405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*